Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy
Type I natural killer T (NKT) cells have gained considerable interest in anticancer immune therapy over the last decade. This “innate-like” T lymphocyte subset has the unique ability to recognize foreign and self-derived glycolipid antigens in association with the CD1d molecule expressed by antigen-...
Main Authors: | Reem Ghinnagow, Luis Javier Cruz, Elodie Macho-Fernandez, Christelle Faveeuw, François Trottein |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.00879/full |
Similar Items
-
Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses
by: Reem Ghinnagow, et al.
Published: (2017-09-01) -
Role of natural killer T lymphocytes during helminthic infection
by: Faveeuw C., et al.
Published: (2008-09-01) -
Optimisation de l'activité immunostimulatrice des lymphocytes T Natural Killer invariants : conséquences sur l'immunité anti-tumorale
by: Ghinnagow, Reem
Published: (2017) -
Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice
by: Jing Huang, et al.
Published: (2020-08-01) -
Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
by: François Trottein, et al.
Published: (2018-08-01)